Wayne Brisbane, MD, presented “Micro-ultrasound and MRI for Visualization of Prostate Cancer” during the 7th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 21, 2023.
This content is available free to the GRU Community. Login or create an account to view it.
How to cite: Brisbane, Wayne. “Micro-ultrasound and MRI for Visualization of Prostate Cancer.” September 21, 2023. Accessed Nov 2024. https://grandroundsinurology.com/micro-ultrasound-and-mri-for-visualization-of-prostate-cancer/
Micro-ultrasound and MRI for Visualization of Prostate Cancer – Summary
Wayne Brisbane, MD, explores micro-ultrasound (micro-US) and MRI in visualizing prostate cancer, highlighting their respective strengths and applications in clinical practice.
Micro-ultrasound has emerged as a promising imaging modality for prostate cancer detection due to its high resolution and real-time capabilities. This technology enhances the identification and characterization of suspicious lesions, offering superior spatial resolution. In contrast, MRI, particularly multiparametric MRI (mpMRI), excels in detecting larger and more complex tumors.
Dr. Brisbane emphasizes that while mpMRI remains pivotal in pre-biopsy evaluations and treatment planning, micro-ultrasound complements these efforts by enhancing real-time visualization during targeted biopsies and focal therapies. Combining the strengths of both modalities allows clinicians to leverage the high sensitivity of mpMRI for initial lesion detection and the high resolution and real-time capabilities of micro-ultrasound for precise biopsy guidance and treatment monitoring.
The Global Summit on Precision Diagnosis and Treatment of Prostate Cancer is a unique multi-disciplinary forum organized to inform the key health care stakeholders about the emerging advances in clinical case and research and create a consensus-based vision for the future of precision care and educational and research strategy for its realization. The mission of the Summit is to fill the currently existing gap between the key experts of in vivo imaging, the world authorities in the in vitro fluid- and tissue-based molecular diagnostics, including genomics, and thought leaders in the development of novel observation strategies (e.g., active surveillance, or AS) and therapeutic interventions.
ABOUT THE AUTHOR
Wayne G. Brisbane, MD, is an assistant professor of urology. Dr. Brisbane received his medical degree from Loma Linda University School of Medicine. He completed a General Surgery internship and Urology residency at the University of Washington. He completed his Urologic Oncology fellowship at UCLA, focusing on prostate cancer.
